Last reviewed · How we verify
Customized Treatment
Customized Treatment refers to personalized therapeutic approaches tailored to individual patient tumor characteristics and molecular profiles in thoracic oncology.
Customized Treatment refers to personalized therapeutic approaches tailored to individual patient tumor characteristics and molecular profiles in thoracic oncology. Used for Thoracic malignancies (lung cancer and related thoracic tumors).
At a glance
| Generic name | Customized Treatment |
|---|---|
| Sponsor | Intergroupe Francophone de Cancerologie Thoracique |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
Rather than a single drug entity, this represents a treatment strategy developed by the Intergroupe Francophone de Cancerologie Thoracique (French-speaking Thoracic Oncology Group) that customizes cancer therapy based on patient-specific factors such as tumor genetics, histology, and biomarkers. The approach aims to optimize efficacy by matching therapeutic interventions to individual disease characteristics.
Approved indications
- Thoracic malignancies (lung cancer and related thoracic tumors)
Common side effects
Key clinical trials
- Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity (NA)
- Early Surgical Intervention of Congenital Hemivertebra in Young Children (NA)
- A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection (PHASE1, PHASE2)
- The Effect of Earplugs on Gag Reflex and Patient Comfort in Root Canal Treatment (NA)
- Randomized Controlled Trial on Precision Mental Health (NA)
- A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults (NA)
- Cognitive Rehabilitation in Post-stroke Cognitive Impairment (NA)
- Lymphoedema Diagnosis and Treatment
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Customized Treatment CI brief — competitive landscape report
- Customized Treatment updates RSS · CI watch RSS
- Intergroupe Francophone de Cancerologie Thoracique portfolio CI